Amy H. Case

Amy H. Case

Intensive Care Medicine | Pulmonary Medicine

275 Collier Road NW
Suite 300
Atlanta, GA 30309

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Deupirfenidone compared with pirfenidone and placebo in idiopathic pulmonary fibrosis (ELEVATE-IPF): a phase 2b randomized placebo-controlled trial.

Deupirfenidone compared with pirfenidone and placebo in idiopathic pulmonary fibrosis (ELEVATE-IPF): a phase 2b randomized placebo-controlled trial.

Journal: American journal of respiratory and critical care medicine

Published: December 12, 2025

Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial.

Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled Trial.

Journal: American journal of respiratory and critical care medicine

Published: December 12, 2025

Reply to Borrás-Blasco et al.: How Adherence Shapes Persistence in IPF Treatment: A Call for Real-World Insight.

Reply to Borrás-Blasco et al.: How Adherence Shapes Persistence in IPF Treatment: A Call for Real-World Insight.

Journal: Annals of the American Thoracic Society

Published: September 12, 2025

Objective clinical scoring system and diagnostic variability in idiopathic pulmonary fibrosis.

Objective clinical scoring system and diagnostic variability in idiopathic pulmonary fibrosis.

Journal: BMC pulmonary medicine

Published: October 24, 2024

Persistence of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis: A Pulmonary Fibrosis Foundation Patient Registry Study.

Persistence of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis: A Pulmonary Fibrosis Foundation Patient Registry Study.

Journal: Annals of the American Thoracic Society

Published: October 15, 2024

Predictors of Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry.

Predictors of Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry.

Journal: Lung

Published: October 02, 2024

Practice Patterns for Screening and Treating Interstitial Lung Disease-related Pulmonary Hypertension at Specialty Care Centers in the United States.

Practice Patterns for Screening and Treating Interstitial Lung Disease-related Pulmonary Hypertension at Specialty Care Centers in the United States.

Journal: Annals of the American Thoracic Society

Published: April 16, 2024

Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE.

Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE.

Journal: Annals of the American Thoracic Society

Published: November 10, 2023

Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey.

Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey.

Journal: BMJ open respiratory research

Published: December 23, 2022

Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.

Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.

Journal: American journal of respiratory and critical care medicine

Published: March 15, 2022

Clinical Overview of Progressive Fibrotic Interstitial Lung Disease.

Clinical Overview of Progressive Fibrotic Interstitial Lung Disease.

Journal: Frontiers in medicine

Published: January 19, 2022

The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis.

The Impact of the Envisia Genomic Classifier in the Diagnosis and Management of Patients with Idiopathic Pulmonary Fibrosis.

Journal: Annals of the American Thoracic Society

Published: December 10, 2021

Showing 1-12 of 21

Last Updated: 09/26/2026